Why the study?
Atrial fibrillation prevalence is projected to double in coming decades, requiring innovative management strategies such as decentralised clinical trial models for home-based monitoring.
Is a decentralized clinical trial for home-based sleep apnoea screening, activity tracking, and heart rhythm monitoring feasible in patients with atrial fibrillation?
Is a decentralized clinical trial for home-based sleep apnoea screening, activity tracking, and heart rhythm monitoring feasible in patients with atrial fibrillation?
Answers are grounded in this paper and cite their sources.
A decentralized digital platform for comprehensive home-based monitoring in patients with atrial fibrillation is highly feasible, achieving high data completeness and low drop-out rates.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Al‐Alak et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: